Concomitant Constitutive LNK and NFE2 Mutation with Loss of Sumoylation in a Case of Hereditary Thrombocythemia

Overview

Journal Haematologica

Specialty Hematology

Date 2020 Jun 20

PMID 32554556

Authors

Lukas Clemens Bockelmann

Titiksha Basu

Albert Grunder

Wei Wang

Jan Breucker

Sandra Kaiser

Andrea Pichler

Heike Luise Pahl

Affiliations

Soon will be listed here.

References

Goerttler P, Kreutz C, Donauer J, Faller D, Maiwald T, Marz E . Gene expression profiling in polycythaemia vera: overexpression of transcription factor NF-E2. Br J Haematol. 2005; 129(1):138-50. DOI: 10.1111/j.1365-2141.2005.05416.x. View

Jutzi J, Basu T, Pellmann M, Kaiser S, Steinemann D, Sanders M . Altered NFE2 activity predisposes to leukemic transformation and myelosarcoma with AML-specific aberrations. Blood. 2019; 133(16):1766-1777. PMC: 6484461. DOI: 10.1182/blood-2018-09-875047. View

Koidl S, Eisenhardt N, Fatouros C, Droescher M, Chaugule V, Pichler A . The SUMO2/3 specific E3 ligase ZNF451-1 regulates PML stability. Int J Biochem Cell Biol. 2016; 79:478-487. DOI: 10.1016/j.biocel.2016.06.011. View

McMullin M, Cario H . LNK mutations and myeloproliferative disorders. Am J Hematol. 2015; 91(2):248-51. DOI: 10.1002/ajh.24259. View

Shyu Y, Lee T, Ting C, Wen S, Hsieh L, Li Y . Sumoylation of p45/NF-E2: nuclear positioning and transcriptional activation of the mammalian beta-like globin gene locus. Mol Cell Biol. 2005; 25(23):10365-78. PMC: 1291221. DOI: 10.1128/MCB.25.23.10365-10378.2005. View

Pichler A, Knipscheer P, Saitoh H, Sixma T, Melchior F . The RanBP2 SUMO E3 ligase is neither HECT- nor RING-type. Nat Struct Mol Biol. 2004; 11(10):984-91. DOI: 10.1038/nsmb834. View

Gasiorek J, Blank V . Regulation and function of the NFE2 transcription factor in hematopoietic and non-hematopoietic cells. Cell Mol Life Sci. 2015; 72(12):2323-35. PMC: 11114048. DOI: 10.1007/s00018-015-1866-6. View

Rumi E, Harutyunyan A, Pietra D, Milosevic Feenstra J, Cavalloni C, Roncoroni E . LNK mutations in familial myeloproliferative neoplasms. Blood. 2016; 128(1):144-5. DOI: 10.1182/blood-2016-04-711150. View

Rabellino A, Andreani C, Scaglioni P . The Role of PIAS SUMO E3-Ligases in Cancer. Cancer Res. 2017; 77(7):1542-1547. PMC: 5380518. DOI: 10.1158/0008-5472.CAN-16-2958. View

10.

Wiestner A, Schlemper R, van der Maas A, Skoda R . An activating splice donor mutation in the thrombopoietin gene causes hereditary thrombocythaemia. Nat Genet. 1998; 18(1):49-52. DOI: 10.1038/ng0198-49. View

11.

Oh S, Simonds E, Jones C, Hale M, Goltsev Y, Gibbs Jr K . Novel mutations in the inhibitory adaptor protein LNK drive JAK-STAT signaling in patients with myeloproliferative neoplasms. Blood. 2010; 116(6):988-92. PMC: 2924231. DOI: 10.1182/blood-2010-02-270108. View

12.

Jutzi J, Bogeska R, Nikoloski G, Schmid C, Seeger T, Stegelmann F . MPN patients harbor recurrent truncating mutations in transcription factor NF-E2. J Exp Med. 2013; 210(5):1003-19. PMC: 3646501. DOI: 10.1084/jem.20120521. View

13.

Motohashi H, Katsuoka F, Miyoshi C, Uchimura Y, Saitoh H, Francastel C . MafG sumoylation is required for active transcriptional repression. Mol Cell Biol. 2006; 26(12):4652-63. PMC: 1489127. DOI: 10.1128/MCB.02193-05. View

14.

Kaufmann K, Grunder A, Hadlich T, Wehrle J, Gothwal M, Bogeska R . A novel murine model of myeloproliferative disorders generated by overexpression of the transcription factor NF-E2. J Exp Med. 2012; 209(1):35-50. PMC: 3260873. DOI: 10.1084/jem.20110540. View

15.

Lallemand-Breitenbach V, de The H . PML nuclear bodies: from architecture to function. Curr Opin Cell Biol. 2018; 52:154-161. DOI: 10.1016/j.ceb.2018.03.011. View